FAM
CBIO

Fred Alger Management’s Crescent Biopharma CBIO Stock Holding History

Fred Alger Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-550
Closed -$125K – 535
2020
Q1 		$125K Sell
550
-50
-8% -$19.1K ﹤0.01% 405
2019
Q4 		$317K Hold
600
– – ﹤0.01% 402
2019
Q3 		$259K Buy
600
+200
+50% +$129K ﹤0.01% 397
2019
Q2 		$477K Buy
+400
New +$478K ﹤0.01% 384
2018
Q2 		– Sell
-70
Closed -$114K – 558
2018
Q1 		$114K Buy
70
+50
+250% +$104K ﹤0.01% 404
2017
Q4 		$34K Buy
+20
New +$26.4K ﹤0.01% 442

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return